RadNet Share Holder Equity 2012-2026 | RDNT
RadNet share holder equity from 2012 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
|
RadNet Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $1,356 |
| 2024 | $1,133 |
| 2023 | $813 |
| 2022 | $491 |
| 2021 | $346 |
| 2020 | $258 |
| 2019 | $233 |
| 2018 | $200 |
| 2017 | $70 |
| 2016 | $52 |
| 2015 | $36 |
| 2014 | $8 |
| 2013 | $2 |
| 2012 | $-7 |
| 2011 | $-70 |
|
RadNet Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-12-31 | $1,356 |
| 2025-09-30 | $1,314 |
| 2025-06-30 | $1,179 |
| 2025-03-31 | $1,137 |
| 2024-12-31 | $1,133 |
| 2024-09-30 | $1,120 |
| 2024-06-30 | $1,093 |
| 2024-03-31 | $1,077 |
| 2023-12-31 | $813 |
| 2023-09-30 | $796 |
| 2023-06-30 | $761 |
| 2023-03-31 | $493 |
| 2022-12-31 | $491 |
| 2022-09-30 | $458 |
| 2022-06-30 | $451 |
| 2022-03-31 | $421 |
| 2021-12-31 | $346 |
| 2021-09-30 | $339 |
| 2021-06-30 | $299 |
| 2021-03-31 | $281 |
| 2020-12-31 | $258 |
| 2020-09-30 | $246 |
| 2020-06-30 | $233 |
| 2020-03-31 | $207 |
| 2019-12-31 | $233 |
| 2019-09-30 | $215 |
| 2019-06-30 | $212 |
| 2019-03-31 | $214 |
| 2018-12-31 | $200 |
| 2018-09-30 | $121 |
| 2018-06-30 | $125 |
| 2018-03-31 | $116 |
| 2017-12-31 | $70 |
| 2017-09-30 | $74 |
| 2017-06-30 | $64 |
| 2017-03-31 | $53 |
| 2016-12-31 | $52 |
| 2016-09-30 | $40 |
| 2016-06-30 | $37 |
| 2016-03-31 | $38 |
| 2015-12-31 | $36 |
| 2015-09-30 | $26 |
| 2015-06-30 | $12 |
| 2015-03-31 | $7 |
| 2014-12-31 | $8 |
| 2014-09-30 | $3 |
| 2014-06-30 | $-3 |
| 2014-03-31 | $-9 |
| 2013-12-31 | $2 |
| 2013-09-30 | $0 |
| 2013-06-30 | $5 |
| 2013-03-31 | $2 |
| 2012-12-31 | $-7 |
| 2012-09-30 | $-59 |
| 2012-06-30 | $-65 |
| 2012-03-31 | $-69 |
| 2011-12-31 | $-70 |
| 2011-09-30 | $-76 |
| 2011-06-30 | $-77 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.302B | $2.040B |
| RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |